Literature DB >> 17111122

High-molecular tenascin-C as an indicator of atypical cells in oral brush biopsies.

O Driemel1, R Dahse, A Berndt, H Pistner, S G Hakim, L Zardi, T E Reichert, H Kosmehl.   

Abstract

Tumour-invasion like wound healing is characterised by the formation of an extracellular matrix with a high tenascin-C content. The tenascin-C molecule undergoes alternative splicing. Analysis using antibody BC2 indicates that especially the high-molecular tenascin-C (hm tn-C) variants are typically tumour-associated, while distribution in normal tissue is restrictive. This study investigated whether hm tn-C is a suitable indicator of atypical cells with invasive potential in oral brush biopsies. One hundred fifty nine consecutive oral brush biopsies with histopathological diagnoses were analysed for the identification of atypical cells. A standardised haematoxylin and eosin staining plus standardised immunocytochemistry using the monoclonal anti-hm tn-C antibody was performed. The bound hm tn-C antibodies were detected with the streptavidine/alkaline phosphatase technique in the autostainer. Conventional cytology produced four false-positives when identifying atypical cells in brush biopsies of inflammatory/benign hyperproliferative mucosa (specificity 96%), while 10 in 52 carcinomas and three of eight recurrences were not identified (sensitivity 78%). Ten of these 13 non-identified tumours could be marked when adding the hm tn-C assay (increasing specificity to 99%). Combining the two assays also reduced the false-positive outcomes from four to one (increasing sensitivity to 95%). The positive and negative predictive values were 92 and 88% for conventional cytology vs 98 and 97% for the dual assay. (1) A 95%-sensitivity proves hm tn-C assisted conventional cytology to be a suitable means of identifying atypical cells in oral brush biopsies. (2) The positive (98%) and negative (97%) predictive values obtained approximate hm tn-C assisted conventional cytology to laminin-5 (100/97%).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17111122     DOI: 10.1007/s00784-006-0086-8

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  30 in total

1.  Very early cytological and DNA-cytometric diagnosis of in situ carcinoma in an immunosuppressed liver transplant recipient.

Authors:  A Burkhardt
Journal:  J Oral Pathol Med       Date:  2006-09       Impact factor: 4.253

2.  Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group.

Authors:  J J Sciubba
Journal:  J Am Dent Assoc       Date:  1999-10       Impact factor: 3.634

3.  Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma.

Authors:  K Emoto; Y Yamada; H Sawada; H Fujimoto; M Ueno; T Takayama; K Kamada; A Naito; S Hirao; Y Nakajima
Journal:  Cancer       Date:  2001-09-15       Impact factor: 6.860

4.  Human tenascin-C: identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae.

Authors:  A J Mighell; J Thompson; W J Hume; A F Markham; P A Robinson
Journal:  Int J Cancer       Date:  1997-07-17       Impact factor: 7.396

5.  Clinical significance of tenascin-C expression in osteosarcoma: tenascin-C promotes distant metastases of osteosarcoma.

Authors:  M Tanaka; T Yamazaki; N Araki; H Yoshikawa; T Yoshida; T Sakakura; A Uchida
Journal:  Int J Mol Med       Date:  2000-05       Impact factor: 4.101

6.  Value of tenascin-C content and association with clinicopathological parameters in uterine cervical lesions.

Authors:  Huseyin Buyukbayram; Adem Arslan
Journal:  Int J Cancer       Date:  2002-08-20       Impact factor: 7.396

7.  Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues.

Authors:  L Borsi; B Carnemolla; G Nicolò; B Spina; G Tanara; L Zardi
Journal:  Int J Cancer       Date:  1992-11-11       Impact factor: 7.396

Review 8.  Tenascins.

Authors:  Ruth Chiquet-Ehrismann
Journal:  Int J Biochem Cell Biol       Date:  2004-06       Impact factor: 5.085

9.  A minimally invasive immunocytochemical approach to early detection of oral squamous cell carcinoma and dysplasia.

Authors:  I S Scott; E Odell; P Chatrath; L S Morris; R J Davies; S L Vowler; R A Laskey; N Coleman
Journal:  Br J Cancer       Date:  2006-04-24       Impact factor: 7.640

10.  Diagnostic value of nucleolar organizer regions (AgNORs) in brush biopsies of suspicious lesions of the oral cavity.

Authors:  Torsten W Remmerbach; Horst Weidenbach; Conrad Müller; Alexander Hemprich; Natalja Pomjanski; Birgit Buckstegge; Alfred Böcking
Journal:  Anal Cell Pathol       Date:  2003       Impact factor: 2.916

View more
  16 in total

1.  Clinical and cytological study of the oral mucosa of smoking and non-smoking qat chewers in Yemen.

Authors:  M Hijazi; H Jentsch; J Al-Sanabani; M Tawfik; T W Remmerbach
Journal:  Clin Oral Investig       Date:  2015-08-29       Impact factor: 3.573

2.  MAGE-A antigens in lesions of the oral mucosa.

Authors:  Eva Krauss; Stephan Rauthe; Stefan Gattenlöhner; Tobias Reuther; Michael Kochel; Ulrike Kriegebaum; Alexander C Kübler; Urs D A Müller-Richter
Journal:  Clin Oral Investig       Date:  2010-02-20       Impact factor: 3.573

Review 3.  [Oral cytology: historical development, current status, and perspectives].

Authors:  M Hullmann; T E Reichert; R Dahse; F von Eggeling; H Pistner; H Kosmehl; O Driemel
Journal:  Mund Kiefer Gesichtschir       Date:  2007-01

4.  Use of endoscopy with narrow-band imaging system in detecting squamous cell carcinoma in oral chronic non-healing ulcers.

Authors:  Shih-Wei Yang; Yun-Shien Lee; Liang-Che Chang; Cheng-Cheng Hwang; Tai-An Chen
Journal:  Clin Oral Investig       Date:  2013-07-09       Impact factor: 3.573

Review 5.  Molecular mechanisms of head and neck cancer.

Authors:  Amit M Deshpande; David T Wong
Journal:  Expert Rev Anticancer Ther       Date:  2008-05       Impact factor: 4.512

6.  Diagnostic efficiency of differentiating small cancerous and precancerous lesions using mucosal brush smears of the oral cavity--a prospective and blinded study.

Authors:  Felix Peter Koch; Martin Kunkel; Stefan Biesterfeld; Wilfried Wagner
Journal:  Clin Oral Investig       Date:  2010-07-01       Impact factor: 3.573

7.  Evaluation of the Ki-67 and MCM3 Expression in Cytologic Smear of Oral Squamous Cell Carcinoma.

Authors:  Fahimeh Rezazadeh; Rahele Ebrahimi; Azadeh Andisheh-Tadbir; Mohammad Javad Ashraf; Bijan Khademi
Journal:  J Dent (Shiraz)       Date:  2017-09

Review 8.  Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.

Authors:  Richard Macey; Tanya Walsh; Paul Brocklehurst; Alexander R Kerr; Joseph L Y Liu; Mark W Lingen; Graham R Ogden; Saman Warnakulasuriya; Crispian Scully
Journal:  Cochrane Database Syst Rev       Date:  2015-05-29

Review 9.  Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer.

Authors:  Alexander Berndt; Petra Richter; Hartwig Kosmehl; Marcus Franz
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

10.  Immunohistochemical expression of basement membrane proteins of verrucous carcinoma of the oral mucosa.

Authors:  Paolo G Arduino; Marco Carrozzo; Marco Pagano; Roberto Broccoletti; Crispian Scully; Sergio Gandolfo
Journal:  Clin Oral Investig       Date:  2009-06-09       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.